{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:24:03Z","timestamp":1783113843136,"version":"3.54.6"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["BJKJ2024054"],"award-info":[{"award-number":["BJKJ2024054"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["24520713200"],"award-info":[{"award-number":["24520713200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52333014"],"award-info":[{"award-number":["52333014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22575086"],"award-info":[{"award-number":["22575086"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.actbio.2026.05.017","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:19:15Z","timestamp":1778825955000},"page":"680-696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A cascade-responsive nanoplatform for cyclooxygenase-2 inhibition and inflammation regulation to enhance photoimmunotherapy"],"prefix":"10.1016","volume":"217","author":[{"given":"Jingyan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7391-4522","authenticated-orcid":false,"given":"Jia","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2026.05.017_bib0001","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.actbio.2026.05.017_bib0002","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.3747\/co.27.5223","article-title":"A review of cancer immunotherapy: from the past, to the present, to the future","volume":"27","author":"Esfahani","year":"2020","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.actbio.2026.05.017_bib0003","article-title":"A comprehensive review of immune checkpoint inhibitors for cancer treatment","volume":"143","author":"Hossain","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.actbio.2026.05.017_bib0004","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41571-022-00600-w","article-title":"Immune-checkpoint inhibitors: long-term implications of toxicity","volume":"19","author":"Johnson","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.actbio.2026.05.017_bib0005","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41417-025-00886-9","article-title":"MDSC checkpoint blockade therapy: a new breakthrough point overcoming immunosuppression in cancer immunotherapy","volume":"32","author":"Ibrahim","year":"2025","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.actbio.2026.05.017_bib0006","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41571-024-00902-1","article-title":"Cancer mRNA vaccines: clinical advances and future opportunities","volume":"21","author":"Sayour","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.actbio.2026.05.017_bib0007","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/s41590-025-02308-2","article-title":"Cancer vaccines as enablers of immunotherapy","volume":"26","author":"Khleif","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.actbio.2026.05.017_bib0008","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13045-025-01670-w","article-title":"Cancer vaccines: current status and future directions","volume":"18","author":"Zhou","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.actbio.2026.05.017_bib0009","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41423-024-01207-0","article-title":"CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors","volume":"21","author":"Peng","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.actbio.2026.05.017_bib0010","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41587-025-02629-5","article-title":"Engineering innate immune cells for cancer immunotherapy","volume":"43","author":"Tarannum","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.actbio.2026.05.017_bib0011","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40425-015-0067-z","article-title":"Combination immunotherapy with alpha-CTLA-4 and alpha-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma","volume":"3","author":"Lussier","year":"2015","journal-title":"J. Immun. Other Cancer"},{"key":"10.1016\/j.actbio.2026.05.017_bib0012","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.57357","article-title":"Long-term survival by number of immune checkpoint inhibitors in PD-L1-negative metastatic NSCLC: a systematic review and meta-analysis","volume":"8","author":"Ponvilawan","year":"2025","journal-title":"JAMa Netw. Open."},{"key":"10.1016\/j.actbio.2026.05.017_bib0013","article-title":"Inducing immunogenic cancer cell death through oxygen-economized photodynamic therapy with nitric oxide-releasing photosensitizers","volume":"63","author":"Xu","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.actbio.2026.05.017_bib0014","article-title":"Innate immune activation with multifunctional nanoparticles for cancer immunotherapy","volume":"64","author":"Jiang","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.actbio.2026.05.017_bib0015","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202423550","article-title":"Synergistic cancer photoimmunotherapy by harnessing near-infrared-activated nanoparticles containing charge transfer complexes","volume":"64","author":"Lim","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.actbio.2026.05.017_bib0016","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.3390\/ijms24032655","article-title":"Near Infrared photoimmunotherapy: a review of recent progress and their target molecules for cancer therapy","volume":"24","author":"Mohiuddin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.actbio.2026.05.017_bib0017","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1021\/acs.accounts.9b00273","article-title":"Near-infrared photoimmunotherapy of cancer","volume":"52","author":"Kobayashi","year":"2019","journal-title":"Acc. Chem. Res"},{"key":"10.1016\/j.actbio.2026.05.017_bib0018","doi-asserted-by":"crossref","first-page":"24972","DOI":"10.1021\/acsnano.3c07183","article-title":"Hypoxia-responsive golgi-targeted prodrug assembled with anthracycline for improved antitumor and antimetastasis efficacy","volume":"17","author":"Guo","year":"2023","journal-title":"ACS. Nano"},{"key":"10.1016\/j.actbio.2026.05.017_bib0019","article-title":"A one stone three birds paradigm of photon-driven pyroptosis dye for amplifying tumor immunotherapy","volume":"12","author":"Zeng","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.actbio.2026.05.017_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123107","article-title":"An all-in-one PEGylated NIR-II conjugated polymer for high-resolution blood circulation imaging and photothermal immunotherapy","volume":"317","author":"Zheng","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2026.05.017_bib0021","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202484761","article-title":"Near-infrared heptamethine cyanine photosensitizers with efficient singlet oxygen generation for anticancer photodynamic therapy","volume":"63","author":"Liu","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.actbio.2026.05.017_bib0022","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202414146","article-title":"Self-assembled peptide-derived proteolysis-targeting Chimera (PROTAC) nanoparticles for tumor-targeted and durable PD-L1 degradation in cancer immunotherapy","volume":"64","author":"Moon","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.actbio.2026.05.017_bib0023","article-title":"Tumor homing chimeric peptide rhomboids to improve photodynamic performance by inhibiting therapy-upregulated cyclooxygenase-2","volume":"20","author":"Zhang","year":"2024","journal-title":"Small."},{"key":"10.1016\/j.actbio.2026.05.017_bib0024","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccr.2005.02.013","article-title":"Smoldering and polarized inflammation in the initiation and promotion of malignant disease","volume":"7","author":"Balkwill","year":"2005","journal-title":"Cancer Cell."},{"key":"10.1016\/j.actbio.2026.05.017_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122954","article-title":"Emerging COX-2 inhibitors-based nanotherapeutics for cancer diagnosis and treatment","volume":"315","author":"Huang","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2026.05.017_bib0026","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1073\/pnas.1602023113","article-title":"PGE2 induced in and released by dying cells functions as an inhibitory DAMP","volume":"113","author":"Hangai","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.actbio.2026.05.017_bib0027","article-title":"A self-delivery nanodrug simultaneously inhibits COX-2\/PGE2 mediated inflammation and downregulates PD-L1 to boost photoimmunotherapy","volume":"13","author":"Lai","year":"2024","journal-title":"Adv Heal. Mater"},{"key":"10.1016\/j.actbio.2026.05.017_bib0028","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3390\/ijms23031432","article-title":"NSAIDs and cancer resolution: new paradigms beyond cyclooxygenase","volume":"23","author":"Kolawole","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.actbio.2026.05.017_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122695","article-title":"Integration of STING activation and COX-2 inhibition via steric-hindrance effect tuned nanoreactors for cancer chemoimmunotherapy","volume":"311","author":"Zhang","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2026.05.017_bib0030","article-title":"A poly-prodrug nanosphere for modulating janus-faced nature of pyroptosis to launch an immune offensive and defensive warfare reigniting the cancer-immunity cycle","volume":"35","author":"Han","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.actbio.2026.05.017_bib0031","article-title":"Glycosylated AIE-active red light-triggered photocage with precisely tumor targeting capability for synergistic type I photodynamic therapy and CPT Chemotherapy","volume":"64","author":"Zhou","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.actbio.2026.05.017_bib0032","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202425309","article-title":"Near-infrared light-responsive immunomodulator prodrugs rejuvenating immune microenvironment for \"cold\" tumor photoimmunotherapy","volume":"64","author":"Shen","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.actbio.2026.05.017_bib0033","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1021\/acs.biomac.5c00321","article-title":"Magnetic induction heating enables on-demand drug release via diels\u2013Alder polymeric nanocarriers","volume":"26","author":"Fujisawa","year":"2025","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2026.05.017_bib0034","article-title":"Ultrasound-activated sonophage synergizes sonodynamic therapy and saltoptosis for solid tumor eradication","volume":"38","author":"Chen","year":"2026","journal-title":"Adv. Mater."},{"key":"10.1016\/j.actbio.2026.05.017_bib0035","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202507388","article-title":"Ultrasound-responsive lipid nanosonosensitizers with size reduction and NO release: synergistic sonodynamic-chemo-immunotherapy for pancreatic tumors","volume":"64","author":"Fang","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.actbio.2026.05.017_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2023.112328","article-title":"A near-infrared bacteriochlorin nanomedicine for enhanced photodynamic therapy","volume":"197","author":"Xian","year":"2023","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.actbio.2026.05.017_bib0037","first-page":"475","article-title":"COX-2 induces apoptosis-resistance in hepatocellular carcinoma cells via the HIF-1\u03b1\/PKM2 pathway","volume":"43","author":"Wang","year":"2019","journal-title":"Int. J. Mol. Med"},{"key":"10.1016\/j.actbio.2026.05.017_bib0038","article-title":"Aminopeptidase N-responsive conjugates with tunable charge-reversal properties for highly efficient tumor accumulation and penetration","volume":"62","author":"Sun","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.actbio.2026.05.017_bib0039","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2321545121","article-title":"A TME-enlightened protein-binding photodynamic nanoinhibitor for highly effective oncology treatment","volume":"121","author":"Cui","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.actbio.2026.05.017_bib0040","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.actbio.2026.05.017_bib0041","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/biomedicines13040950","article-title":"Immunogenic cell death and metabolic reprogramming in cancer: mechanisms, synergies, and innovative therapeutic strategies","volume":"13","author":"Jiang","year":"2025","journal-title":"Biomedicines."},{"key":"10.1016\/j.actbio.2026.05.017_bib0042","doi-asserted-by":"crossref","first-page":"8991","DOI":"10.1021\/jacs.3c13224","article-title":"Augmenting cancer therapy with a supramolecular immunogenic cell death inducer: a lysosome-targeted NIR-light-activated ruthenium(II) metallacycle","volume":"146","author":"Tu","year":"2024","journal-title":"J. Am. Chem. Soc"},{"key":"10.1016\/j.actbio.2026.05.017_bib0043","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1039\/D5MD00196J","article-title":"Recent advances in targeting COX-2 for cancer therapy: a review","volume":"16","author":"Kassab","year":"2025","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.actbio.2026.05.017_bib0044","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.3390\/ijms25116103","article-title":"NOS2 and COX-2 Co-expression promotes cancer progression: a potential target for developing agents to prevent or treat highly aggressive breast cancer","volume":"25","author":"Coutinho","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.actbio.2026.05.017_bib0045","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"Single-component dual-functional autoboost strategy by dual photodynamic and cyclooxygenase-2 inhibition for lung cancer and spinal metastasis","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.actbio.2026.05.017_bib0046","article-title":"Cyclooxygenase-2\/prostaglandin E2 inhibition remodulated photodynamic therapy-associated immunosuppression for enhanced cancer immunotherapy","volume":"31","author":"Xu","year":"2025","journal-title":"Mater. Today Bio."},{"key":"10.1016\/j.actbio.2026.05.017_bib0047","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13046-025-03377-9","article-title":"Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy","volume":"44","author":"Yang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2026.05.017_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1691392","article-title":"Celecoxib in oncology: targeting the COX-2\/PGE2 axis to reprogram the tumor immune microenvironment and enhance multimodal therapy","volume":"16","author":"Kuang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.actbio.2026.05.017_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2025.112617","article-title":"Breaking immune evasion in breast cancer by targeting COX-2\/PGE2 pathway","volume":"608","author":"Zheng","year":"2025","journal-title":"Mol. Cell. Endocrinol"},{"key":"10.1016\/j.actbio.2026.05.017_bib0050","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2026.05.017_bib0051","article-title":"Photodynamic therapy-induced inflammation and adverse effects: an updated review","author":"Moloudi","year":"2025","journal-title":"Biomed. J."},{"key":"10.1016\/j.actbio.2026.05.017_bib0052","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/sj.bjc.6600864","article-title":"Role of cytokines in photodynamic therapy-induced local and systemic inflammation","volume":"88","author":"Gollnick","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.actbio.2026.05.017_bib0053","doi-asserted-by":"crossref","first-page":"7908","DOI":"10.1021\/jacs.4c17966","article-title":"Leveraging immunogenic cell death to enhance the immune response against malignant pleural mesothelioma tumors","volume":"147","author":"Chang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.actbio.2026.05.017_bib0054","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","article-title":"Targeting immunogenic cell stress and death for cancer therapy","volume":"23","author":"Galluzzi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.actbio.2026.05.017_bib0055","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/cancers6031670","article-title":"Tumor-associated macrophages as major players in the tumor microenvironment","volume":"6","author":"Chanmee","year":"2014","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.actbio.2026.05.017_bib0056","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s12951-025-03321-1","article-title":"Macrophage-derived exosomes in cancer: a double-edged sword with therapeutic potential","volume":"23","author":"Liu","year":"2025","journal-title":"J. Nanobiotechnology."},{"key":"10.1016\/j.actbio.2026.05.017_bib0057","article-title":"NIR-II imaging-guided self-enhanced nanomedicine with reactive oxygen species amplification for type I photodynamic therapy of prostate cancer","volume":"35","author":"Chen","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.actbio.2026.05.017_bib0058","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1021\/acs.biomac.9b01123","article-title":"NIR-triggered multifunctional and degradable nanoplatform based on an ROS-sensitive block copolymer for imaging-guided chemo-phototherapy","volume":"20","author":"Wang","year":"2019","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2026.05.017_bib0059","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.3892\/ijo.2016.3421","article-title":"Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1\u03b1 is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery","volume":"48","author":"Huang","year":"2016","journal-title":"Int. J. Oncol"},{"key":"10.1016\/j.actbio.2026.05.017_bib0060","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccr.2005.02.013","article-title":"Smoldering and polarized inflammation in the initiation and promotion of malignant disease","volume":"7","author":"Balkwill","year":"2005","journal-title":"Cancer Cell."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126003090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126003090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:59:20Z","timestamp":1783112360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706126003090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":60,"alternative-id":["S1742706126003090"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2026.05.017","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A cascade-responsive nanoplatform for cyclooxygenase-2 inhibition and inflammation regulation to enhance photoimmunotherapy","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2026.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}